A selective review of medical cannabis in cancer pain management
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
A bill that could legalize medical marijuana in North Carolina is taking a long, winding road through the state Senate, but the bill’s Republican sponsors have managed to get it successfully through several committees.
The Cherokee Tribal Council today approved a 42-page ordinance that will establish a system to support legalized medical marijuana on the Qualla Boundary.
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians.
David Bass, a military veteran diagnosed with post-traumatic stress disorder, at his home in Killeen on Sunday. He’s used illegal marijuana to treat symptoms, but plans to enroll in the state’s medical cannabis program that expands Sept. 1.
Marijuana generally refers to the dried mixture of leaves and flowers of the cannabis plant, and the term cannabis is a commonly used to refer to products derived from the Cannabis sativa L. plant.
The purpose of this report is to present a review of the medical uses, efficacy, and adverse effects of the three approved cannabis-based medications and ingested marijuana.
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain.
Policy discussions amidst recent changes in the legal status of cannabis for medical purposes have raised concerns regarding the diversion of medical cannabis to nonlicensed users.
Fibromyalgia is a chronic pain syndrome, characterized by chronic musculoskeletal pain, fatigue, and mood disturbances. There are nearly no data on the effect of medical cannabis (MC) treatment on patients with fibromyalgia.